Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
The expansion, supported by a significant UK government grant, includes a new lipid system synthesis facility and enhanced R&D capabilities
The goal is to deliver greater value to customers, doctors, and the broader healthcare ecosystem
Includes new $1.2 billion investment in manufacturing facilities, AI and advanced digital technologies, creating hundreds of highly skilled U.S. jobs
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
Maria Soler Nunez appointed as Chief Quality Officer
Subscribe To Our Newsletter & Stay Updated